GC Biotech provides CRO\CDMO services and technologies for vaccine development and manufacturing from discovery to pre-clinical, clinical research, and from adjuvant molecules, recombinant protein to delivery system to vaccine product.
Through tech transfer, technical consultation, and partnership development, we help our customers to deliver affordable and innovative vaccines that help fight a wide range of infectious diseases.
Our integrated, open-access platform helps lower the costs of R&D and expedite the delivery of new vaccines globally.
SOLUTIONS FOR NOVEL VACCINE ADJUVANT
- provide adjuvant molecules for vaccine development
- Offer numerous options for discovery scales, purify levels, modifications
- From simple to the most complex and challenging molecules
-
CMC Development
- process development, pilot scale-up, process validation, API advanced intermediate production
- Analytical method development, quality standard establishment, stability study
- Pre-formulation, formulation development and manufacturing
Comercial Manufacturing
- manufacturing and purification of active pharmaceutical ingredients (APIs) for new chemical entities
At present, the company has established bacterial vaccine technology platform, viral vaccine technology platform, combined vaccine technology platform, gene recombinant protein technology platform, mRNA technology platform, adjuvant technology platform, etc., and has established a core R & D team from well-known domestic scientific research institutions and biological products companies. By making full use of its rich R & D experience, the company is committed to developing innovative vaccines to effectively prevent various infectious diseases, Develop and produce candidate vaccines to respond to known or emerging disease threats. At the same time, we can also provide enterprises, scientific research institutions and medical institutions with self-developed laboratory reagents, verification reagents and professional service guidance. GC Biotech always adheres to innovation, makes breakthroughs, adheres to international standards, and achieves quality first and reputation first. I will mount a long wind some day and break the heavy waves, and set my cloudy sail straight and bridge the deep, deep sea!
